Multicenter treatment and outcome evaluation of aspiration syndromes in critically ill patients

Annals of Pharmacotherapy

Volumn 41, Issue 4, 2007, Pages 549-555

  Kane Gill, Sandra L ^a   Olsen, Keith M ^b   Rebuck, Jill A ^c   Rea, Rhonda S ^a,d,j   Boatwright, D Wesston ^e   Smythe, Maureen A ^f   Walker, Terrence R ^g   Lager, Stephanie L ^h   Hodgman, Tudy ⁱ  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c FLETCHER ALLEN HEALTH CARE   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e Medical Affairs   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g Clinical Affairs   (United States)

^h Heartland Health   (United States)

ⁱ NORTHWEST COMMUNITY HOSPITAL   (United States)

^j PFIZER INC   (United States)

more..

Author keywords

Aspiration syndromes; Critically ill; Intensive care unit; Pneumonia; Pneumonitis

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERTAPENEM; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; ASPIRATION PNEUMONIA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CRITICAL ILLNESS; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NORTH AMERICA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION;

AGED; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTICENTER STUDIES; PNEUMONIA, ASPIRATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34247272937     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H675     Document Type: Article

References (30)

1. Metheny NA. Risk factors for aspiration. JPEN J Parenter Enteral Nutr 2002;26(suppl 6):S26-31.
2. Miller CD, Rebuck JA, Ahern JW, Rogers FB. Daily evaluation of macroaspiration in the critically ill trauma patient. Curr Surg 2005; 62:504-8.
3. DeLegge MH. Aspiration pneumonia: incidence, mortality, and at-risk populations. JPEN J Parenter Enteral Nutr 2002;26(suppl 6):S19-24.
4. Elpern EH, Scott MG, Petro L, Ries MH. Pulmonary aspiration in mechanically ventilated patients with tracheostomies. Chest 1994;105:563-6.
5. McClave SA, DeMeo MT, DeLegge MH, et al. North American Summit on Aspiration in the Critically Ill Patient: consensus statement. JPEN J Parenter Enteral Nutr 2002;26(suppl 6):S80-5.
6. Cameron JL, Mitchell WH, Zuidema GD. Aspiration pneumonia. Clinical outcome following documented aspiration. Arch Surg 1973;106:49-52.
7. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology 1993;78:56-62.
8. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001;344:665-7.
9. Marik PE. Aspiration pneumonia: mixing apples with oranges and tangerines (letter). Crit Care Med 2004;32:1236.
10. Rebuck JA, Rasmussen JR, Olsen KM. Clinical aspiration-related practice patterns in the intensive care unit: a physician survey. Crit Care Med 2001;29:2239-44.
11. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;290:2588-98.
12. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000;162:505-11.
13. Brilli RJ, Spevetz A, Branson RD, et al. Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med 2001;29:2007-19.
14. Paladino JA, Fell RE. Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia. Ann Pharmacother 1994;28:384-9.
15. US Consensus Regions and Divisions. Available at Energy Information Administration. www.eia.doe.gov/emeu/reps/maps/us_census.html (accessed 2007 Feb 7).
16. Shifrin RY, Choplin RH. Aspiration in patients in critical care units. Radiol Clin North Am 1996;34:83-96.
17. Bartlett JG, Gorbach SL, Finegold SM. The bacteriology of aspiration pneumonia. Am J Med 1974;56:202-7.
18. Lorber B, Swenson RM. Bacteriology of aspiration pneumonia. A prospective study of community- and hospital-acquired cases. Ann Intern Med 1974;81:329-31.
19. Hubmayr RD, Burchardi H, Elliot M, et al. Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia - Chicago, Illinois, May 2002. Intensive Care Med 2002;28:1521-36.
20. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343:1925-32.
21. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-5.
22. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-33.
23. American Thoracic Society. Guidelines for the management of adults with hospital acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005,131:388-416.
24. Mier L, Dreyfuss D, Darchy B, et al. Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures. Intensive Care Med 1993;19:279-84.
25. Marik PE, Careau P. The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study. Chest 1999;115:178-83.
26. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005;26:273-80.
27. Gerding DN. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 2004;38:646-8.
28. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000;31(suppl 4):S131-8.
29. Dupont H, Mentec H, Sollet JP, et al. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001;27:355-62.
30. Brun-Buisson C. Guidelines for treatment of hospital-acquired pneumonia. Semin Respir Crit Care Med 2002;23:457-69.